144 related articles for article (PubMed ID: 35388021)
21. CTHRC1 promotes gastric cancer metastasis via HIF-1α/CXCR4 signaling pathway.
Ding X; Huang R; Zhong Y; Cui N; Wang Y; Weng J; Chen L; Zang M
Biomed Pharmacother; 2020 Mar; 123():109742. PubMed ID: 31855733
[TBL] [Abstract][Full Text] [Related]
22. Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway.
Cheng Y; Che X; Zhang S; Guo T; He X; Liu Y; Qu X
Med Sci Monit; 2020 Sep; 26():e925019. PubMed ID: 32881844
[TBL] [Abstract][Full Text] [Related]
23. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
Burger JA; Kipps TJ
Blood; 2006 Mar; 107(5):1761-7. PubMed ID: 16269611
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
26. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.
He H; Wang C; Shen Z; Fang Y; Wang X; Chen W; Liu F; Qin X; Sun Y
PLoS One; 2013; 8(8):e71864. PubMed ID: 23936528
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Jiang Q; Sun Y; Liu X
Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
[No Abstract] [Full Text] [Related]
29. PIEZO2 expression is an independent biomarker prognostic for gastric cancer and represents a potential therapeutic target.
Zhang YC; Yang M; Lu CD; Li QY; Shi JN; Shi J
Sci Rep; 2024 Jan; 14(1):1206. PubMed ID: 38216574
[TBL] [Abstract][Full Text] [Related]
30. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
31. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 is a prognostic marker that inhibits the invasion and migration of gastric cancer by regulating VEGF expression.
Chen G; Zhou Z; Jin J; Zhou Y; Liu Y; Wang W
Oncol Lett; 2021 Aug; 22(2):587. PubMed ID: 34149898
[TBL] [Abstract][Full Text] [Related]
33. Correlation between Chemokine CXCL-12 and ist Receptor CXCR4 Expression is Associated with Clinical Prognosis of Gastric Cancer.
Xu G; Lu K; Shen M; Zhang Q; Pan W; Tang Z
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255293
[TBL] [Abstract][Full Text] [Related]
34. At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.
Luker GD; Yang J; Richmond A; Scala S; Festuccia C; Schottelius M; Wester HJ; Zimmermann J
J Leukoc Biol; 2021 May; 109(5):969-989. PubMed ID: 33104270
[TBL] [Abstract][Full Text] [Related]
35. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis.
Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X
Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 is a Novel Biomarker Correlated With Malignant Transformation and Immune Infiltrates in Gastric Precancerous Lesions.
Jiang X; Zheng J; Liu L; Jiang K; Wen Y; Yan Y; Liu Y; Zhong L; Huang Y; Yao Z; Nie K; Zheng Z; Pan J; Liu P; Zhuang K; Liu F; Xu S; Li P
Front Mol Biosci; 2021; 8():697993. PubMed ID: 34676245
[No Abstract] [Full Text] [Related]
37. CXCR4
Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
